| Autor: |
Valido K; Department of Dermatology, Yale School of Medicine, New Haven, Connecticut., Patel V; Department of Dermatology, Hackensack Meridian Health Palisades Medical Center, North Bergen, New Jersey., Murphy MJ; Department of Dermatology, Yale School of Medicine, New Haven, Connecticut., Junejo MH; Department of Dermatology, Yale School of Medicine, New Haven, Connecticut., Patel DK; Department of Internal Medicine, Northwell Health Lenox Hill Hospital, New York, New York., Deutsch A; Department of Dermatology, Yale School of Medicine, New Haven, Connecticut., Turner N; Department of Dermatology, Yale School of Medicine, New Haven, Connecticut., Zaki TD; Department of Dermatology, Yale School of Medicine, New Haven, Connecticut., King B; Department of Dermatology, Yale School of Medicine, New Haven, Connecticut., Damsky W; Department of Dermatology, Yale School of Medicine, New Haven, Connecticut.; Department of Pathology, Yale School of Medicine, New Haven, Connecticut., Nelson CA; Department of Dermatology, Yale School of Medicine, New Haven, Connecticut. |
| Abstrakt: |
Competing Interests: Dr Damsky is a consultant for Pfizer, Incyte, Eli Lilly, and TWi Biotechnology, and has research funding from Pfizer, Advanced Cell Diagnostics/Bio-techne, and AbbVie and receives licensing fees from EMD/Millipore/Sigma, all outside the submitted work. Dr Nelson has received research grants from Boehringer Ingelheim and participated in an advisory board for work related to pustular psoriasis and palmoplantar pustulosis. All other authors have no relevant conflicts to disclose. |
